MX9207493A - Composicion farmaceutica que contiene compuestos de trioxolano y diperoxido. - Google Patents

Composicion farmaceutica que contiene compuestos de trioxolano y diperoxido.

Info

Publication number
MX9207493A
MX9207493A MX9207493A MX9207493A MX9207493A MX 9207493 A MX9207493 A MX 9207493A MX 9207493 A MX9207493 A MX 9207493A MX 9207493 A MX9207493 A MX 9207493A MX 9207493 A MX9207493 A MX 9207493A
Authority
MX
Mexico
Prior art keywords
trioxolane
pharmaceutical composition
composition containing
diperoxide
compounds
Prior art date
Application number
MX9207493A
Other languages
English (en)
Inventor
Stephen Herman
Original Assignee
Stephen Herman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/840,388 external-priority patent/US5270344A/en
Application filed by Stephen Herman filed Critical Stephen Herman
Publication of MX9207493A publication Critical patent/MX9207493A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Dental Preparations (AREA)

Abstract

La presente invención provee un método de tratamiento médico para enfermedades sistémicas y condiciones faríngeas en un mamífero. En este método, una cantidad farmacológicamente efectiva para el tratamiento de la enfermedad o condición de un trioxolano o un diperóxido de un hidrocarburo insaturado, tal como un terpeno o no terpeno, se aplica al mamífero. La invención también provee composiciones farmacéuticas para uso en estos métodos.
MX9207493A 1991-12-24 1992-12-22 Composicion farmaceutica que contiene compuestos de trioxolano y diperoxido. MX9207493A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81396291A 1991-12-24 1991-12-24
US07/840,388 US5270344A (en) 1988-06-24 1992-02-24 Method of treating a systemic disorder using trioxolane and diperoxide compounds

Publications (1)

Publication Number Publication Date
MX9207493A true MX9207493A (es) 1994-03-31

Family

ID=27123798

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9207493A MX9207493A (es) 1991-12-24 1992-12-22 Composicion farmaceutica que contiene compuestos de trioxolano y diperoxido.

Country Status (6)

Country Link
EP (1) EP0644716A4 (es)
JP (1) JPH08502018A (es)
AU (1) AU3328293A (es)
CA (1) CA2126757A1 (es)
MX (1) MX9207493A (es)
WO (1) WO1993012654A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease
JP3056730B1 (ja) * 1999-03-31 2000-06-26 株式会社バイオ技研 二形性真菌であるカンジダ属に対する形態転換制御活性機能剤
EP1750690A1 (en) * 2004-05-10 2007-02-14 Robert F. Hofmann Use of targeted oxidative therapeutic formulation in treatment of cancer
WO2006002287A1 (en) * 2004-06-23 2006-01-05 Hofmann Robert F Use of targeted oxidative therapeutic formulation in endodontic treatment
US20100041903A1 (en) * 2006-06-28 2010-02-18 Erc Technology Inc. Ozonized Surfactant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1210949A (en) * 1914-07-30 1917-01-02 Gen Res Lab Medicinal compound.
US2083572A (en) * 1928-04-25 1937-06-15 Susan M Mckee Process of treating oil
US2356062A (en) * 1942-02-03 1944-08-15 Latimer Lab Inc Therapeutic composition
US4591602A (en) * 1982-04-16 1986-05-27 James H. Brown Ozonide esters and topical compositions containing same
US4451480A (en) * 1982-04-16 1984-05-29 James Howard Brown Method of treating acne using ozonized materials
US5086076A (en) * 1988-06-24 1992-02-04 Stephen Herman Antiviral pharmaceutical compositions comprising a terpene ozonide
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV

Also Published As

Publication number Publication date
JPH08502018A (ja) 1996-03-05
EP0644716A1 (en) 1995-03-29
AU3328293A (en) 1993-07-28
CA2126757A1 (en) 1993-07-08
EP0644716A4 (en) 1995-04-19
WO1993012654A1 (en) 1993-07-08

Similar Documents

Publication Publication Date Title
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
BR9406979A (pt) Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal
ES2039278T3 (es) Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides.
CO4970691A1 (es) Terapia en combinacion para erradicar vhc-arn detectable en pacientes que padecen infeccion de hepatitis c cronica
GT199700009AA (es) Terapia combinada para la osteoporosis
MX9703556A (es) Composicion para bloquear los rayos solares y para curar heridas.
ES2149812T3 (es) Metodo y composiciones para mejorar el funcionamiento de los leucocitos sobre una superficie mucosa o cutanea.
ES2146300T3 (es) Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos.
MX9304435A (es) Compuesto y composicion farmaceutica para el tratamiento y la profilaxis de la obesidad o para el tratamiento de la diabetes del tipo ii.
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
AR021912A1 (es) Uso de apomorfina para el tratamiento de la disfuncion erectil organica en varones
AR015434A1 (es) Derivados de eritromicina con puente en 6,9, procedimientos para su preparacion, composicion farmaceutica para tratar infecciones bacterianas que los contiene y su uso para la manufactura de un medicamento
BR0010515A (pt) Sistema terapêutico de ministração transdérmica, processo para mascarar um odor desagrádavel e uso de um óleo essencial em um sistema terapéutico de ministração transdérmica
DE69720996D1 (de) Neue pharmazeutische zusammensetzungen von steroid-nitratester zur verwendung als enzündungshemmer
CO5570661A2 (es) Combinaciones que comprenden inhibidores de cox-2 y aspirina
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
DE60334711D1 (de) Zusammensetzungen aus ezetimib und verfahren zur behandlung von mit cholesterin zusammenhängenden gutartigen und bösartigen tumoren
MX9207493A (es) Composicion farmaceutica que contiene compuestos de trioxolano y diperoxido.
KR960030947A (ko) src SH2 특이성 화합물의 골흡수 질환 치료 용도
ES2136167T3 (es) Composiciones de idebenona para tratar la enfermedad de alzheimer.
HUP9801022A2 (hu) Eljárás aldóz reduktáz inhibítor alkalmazása diabetikus szívizom-betegség megelőzésére vagy megfordítására
BR0110396A (pt) Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia
ES2189956T3 (es) Derivados de quinolina, procedimientos para su preparacion y su uso como medicamentos.